Comparison [acty]
effects [qlco]
Continuous [idcn]
HRT [topp]
regimens [inpr]
cardiovascular risk factor [dsyn]
Study [mnob]
effects [qlco]
Continuous [idcn]
HRT [topp]
regimens [inpr]
CARDIOVASCULAR [bdsy]
Markers, Risk [qlco]
postmenopausal [tmco]
Women [popg]
Assigned [ftcn]
Receive [qlco]
tibolone 2.5 MG [clnd]
N NOS [aapp, imft]
mg day [qnco]
Conjugated [spco]
Equine [mamm]
Oestrogens [horm, phsu, strd]
Continuous [idcn]
medroxyprogesterone acetate 5 MG [clnd]
N NOS [aapp, imft]
Serum lipoprotein levels [lbpr]
Including [ftcn]
Nitrate [chvs]
Nitrite [chvs]
weeks [tmco]
therapy [ftcn]
tibolone [phsu, strd]
Reduced [qlco]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
Cholesterol, HDL [bacs, lipd]
P NOS [aapp, imft]
Ratio [qnco]
Cholesterol, HDL2 [bacs, strd]
HDL3 [dsyn]
P NOS [aapp, imft]
Cholesterol, LDL [bacs, strd]
Downward [spco]
trend [tmco]
reduction [npop]
P NOS [aapp, imft]
Percentage [qnco]
Correlated [qlco]
Percentage [qnco]
Triglyceride level [lbtr]
R- [spco]
P NOS [aapp, imft]
Susceptibility [clna]
Oxidation [moft]
Decreased [qnco]
P NOS [aapp, imft]
Lag [gngm]
Highly [qlco]
Correlated [qlco]
Percentage [qnco]
Levels [qlco]
R- [spco]
P NOS [aapp, imft]
Triglycerides [bacs, lipd]
R- [spco]
P NOS [aapp, imft]
Nitrate+Nitrite [inch, phsu]
Contrast [qlco]
Combined therapy [topp]
reduction [npop]
Cholesterol, LDL [bacs, strd]
P NOS [aapp, imft]
Decrease [qlco]
Ii [aapp]
P NOS [aapp, imft]
Ii [aapp]
Correlated [qlco]
Triglyceride level [lbtr]
R- [spco]
P NOS [aapp, imft]
R- [spco]
P NOS [aapp, imft]
Parameter [spco]
Modified [ftcn]
Treatment Effect [fndg]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
Cholesterol, HDL [bacs, lipd]
P NOS [aapp, imft]
Oxidation [moft]
P NOS [aapp, imft]
Ii [aapp]
Ratio [qnco]
P NOS [aapp, imft]
reduction [npop]
Induced [ftcn]
Continuous [idcn]
Combined therapy [topp]
Likely [qlco]
apparent [idcn]
Shift [ftcn]
Profile [lbpr]
tibolone [phsu, strd]
Favorable [qlco]
CARDIOVASCULAR [bdsy]
Suggest [idcn]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
